ENTRY       D05387                      Drug
NAME        Pegaspargase (JAN/USAN/INN);
            Oncaspar (TN)
PRODUCT     ONCASPAR (Servier Pharmaceuticals LLC)
REMARK      Therapeutic category: 4291
            ATC code: L01XX24
            Product: D05387<JP/US>
EFFICACY    Antineoplastic
  DISEASE   Acute lymphoblastic leukemia [DS:H00001 H00002]
COMMENT     PEG-L-asparaginase [KO:K01424] [EC:3.5.1.1]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01X OTHER ANTINEOPLASTIC AGENTS
                L01XX Other antineoplastic agents
                 L01XX24 Pegaspargase
                  D05387  Pegaspargase (JAN/USAN/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antineoplastics
              Antineoplastics, Other
               Pegaspargase
                D05387  Pegaspargase (JAN/USAN/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             4  Agents affecting cellular function
              42  Antineoplastics
               429  Miscellaneous
                4291  Other Antitumors
                 D05387  Pegaspargase (JAN/USAN/INN)
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D05387
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D05387
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D05387
DBLINKS     CAS: 130167-69-0
            PubChem: 47207063
///
